Authors: Tursi A,Giorgetti G,Brandimarte G,Rubino E,Lombardi D,Gasbarrini G,
Address: Division of Internal Medicine, Ospedale Civile Umberto I, Barletta, BA, Italy.
In recent years, an increased incidence of subclinical/silent celiac disease has been reported. Thus, we herein describe the Prevalence and the clinical presentation of subclinical/silent celiac disease in 252 consecutive diagnosed celiac patients.
From 1988 to 1999 we diagnosed 252 celiac patients (74M and 178F, mean age: 27.9 yrs; range: 15-65 yrs, F/M ratio: 2.4). 144 patients were referred to us due to gastrointestinal symptoms, while 108 were referred to us from other specialists due to unexplained or unresponsive disease. All patients underwent both total immunoglobulin A and antigliadin antibodies antiendomysium antibody and evaluation, followed by gastrointestinal endoscopy with duodenal histological examination.
144 (57.14%) and 108 (42.86%) patients showed classical and subclinical/silent celiac disease, respectively. The most frequent extraintestinal marker of subclinical celiac disease were iron-deficiency anemia (27.77%), alopecia and dermatitis herpetiformis (11.36%), osteoporosis (6.81%) and recurrent aphtous stomatitis (5.68%), while first-degree relatives (30%), Basedow's disease (25%) and insulin-dependent diabetes (20%) were the most frequent in silent celiac disease.
This study confirms the extremely polymorphic nature of this condition that can affect several organs and apparatus without gastrointestinal symptoms. However, a more precise description of subclinical/silent celiac disease can only emerge from screening studies on general populations.Related ArticlesChanging trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice?
Minerva Gastroenterol Dietol. ...
Changing trends in clinical form of celiac disease. Which is now the main form of celiac disease in clinical practice?
Brandimarte G, Tursi A, Giorgetti GM. Minerva Gastroenterol Dietol. 2002 Jun; 48(2):121-30. The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases.
Am J Gastroenterol. 1999
The clinical pattern of subclinical/silent celiac disease: an analysis on 1026 consecutive cases.
Bottaro G, Cataldo F, Rotolo N, Spina M, Corazza GR. Am J Gastroenterol. 1999 Mar; 94(3):691-6. Prevalence of occult celiac disease in patients with iron-deficiency anemia: a prospective study.
South Med J. 2004
Prevalence of occult celiac disease in patients with iron-deficiency anemia: a prospective study.
Karnam US, Felder LR, Raskin JB. South Med J. 2004 Jan; 97(1):30-4. Review [Diagnosis and therapy of celiac disease in adolescence and adulthood].
Z Gastroenterol. 2002Review
[Diagnosis and therapy of celiac disease in adolescence and adulthood].
Vogelsang H, Propst A, Dragosics B, Granditsch G, Working Group for Chronic Inflammatory Bowel Diseases of the Austrian Society of Gastroenterology and Hepatology. Z Gastroenterol. 2002 Jul; 40(7):I-VII. Review [Adult celiac disease: study of 21 cases and review of the bibliography].
Gastroenterol Hepatol. 2001Review
[Adult celiac disease: study of 21 cases and review of the bibliography].
Campo López C, Alonso Estellés R, Montero Alonso M, Todolí Parra J, Bosch Aparicio N, Calabuig Alborch J. Gastroenterol Hepatol. 2001 May; 24(5):236-9. Origin of celiac disease: how old are predisposing haplotypes?
World J Gastroenterol. 2012
Origin of celiac disease: how old are predisposing haplotypes?
Gasbarrini G, Rickards O, Martínez-Labarga C, Pacciani E, Chilleri F, Laterza L, Marangi G, Scaldaferri F, Gasbarrini A. World J Gastroenterol. 2012 Oct 7; 18(37):5300-4. Gluten-sensitive enteropathy associated with genital lichen simplex chronicus.
JRSM Short Rep. 2010
Gluten-sensitive enteropathy associated with genital lichen simplex chronicus.
Gach JE, Seddon HF. JRSM Short Rep. 2010 Oct 21; 1(5):43. Epub 2010 Oct 21.Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques.
PLoS One. 2010
Visualization of transepithelial passage of the immunogenic 33-residue peptide from alpha-2 gliadin in gluten-sensitive macaques.
Mazumdar K, Alvarez X, Borda JT, Dufour J, Martin E, Bethune MT, Khosla C, Sestak K. PLoS One. 2010 Apr 19; 5(4):e10228. Epub 2010 Apr 19.